Can a new governor, an oligarch from the region, restore calm in the face of a depressed economy, corruption, and a pro-Russian political establishment?
Lamborghini, Ferrari, Maserati, McLaren, and Porsche are all popular among the filthy rich
The U.S. provides hope that much of the world could eventually avoid both malnutrition and excess nutrition
Microsoft's Xbox One sales need a big boost from exclusive game Titanfall
Comcast might please shareholders by spinning off some 3 million subscribers. How long could the new cable company survive independently?
Groups representing professional photographers prefer to develop ways to pay image creators in place of Getty's tolerance for Web embedding
DIsney's MyMagic+ technology may make a trip to Disney World more magical—or creep customers out
European MBA programs compete with top-tier U.S. schools for the best students at home and abroad
Research suggests that women may turn to entrepreneurship after 50 to support themselves in retirement
Founder: Dr. Eckard Weber
VC Investment over the last four quarters: $30 million
Founded in 2006, nine-employee biotech company Tobira is focusing on developing and commercializing treatments for infectious diseases, including HIV. The company, which was issued a U.S. patent in August for an antiviral compound, is proceeding with its proof of concept study "to demonstrate safety and efficacy in HIV positive patients," says CEO James Sapirstein.
Key to startup success: N/A